References
- Ciechanover, A. 1994. The ubiquitin-proteasome proteolytic pathway. Cell 79, 13-21 https://doi.org/10.1016/0092-8674(94)90396-4
- Clurman, B. E., R. J. Sheaff, K. Thress, M. Groudine and J. M. Roberts. 1996. Turnover of cyclin E by the ubiquitin- proteasome pathway is regulated by cdk2 binding and cyclin phosphorylation. Genes Dev. 10, 1979-1990 https://doi.org/10.1101/gad.10.16.1979
- Choi, Y. H., S. J. Lee, P. Nguyen, J. S. Jang, J. Lee, M. L. Wu, E. Takano, M. Maki, P. A. Henkart and T. B. Trepel. 1997. Regulation of cyclin D1 by calpain protease. J. Biol. Chem. 272, 28479-28484 https://doi.org/10.1074/jbc.272.45.28479
- Dynlacht, B. D. 1997. Regulation of transcription by proteins that control the cell cycle. Nature 389, 149-152 https://doi.org/10.1038/38225
- Franch, H. A. 2002. Pathways of proteolysis affecting renal cell growth. Curr Opin Nephrol. Hypertens. 2002 11: 445-450 https://doi.org/10.1097/00041552-200207000-00012
- Glotzer, M., A. W. Murray and M. W. Kirschner. 1991. Cyclin is degraded by the ubiquitin pathway. Nature 349, 132-138 https://doi.org/10.1038/349132a0
- Goll, D. E., V. F. Thompson, R. G. Taylor and T. Zalewska. 1992. Is calpain activity regulated by membranes and autolysis or by calcium and calpastatin? Bioessays 14, 549-556 https://doi.org/10.1002/bies.950140810
- Gonen, H., D. Shkedy, S. Barnoy, N. S. Kosower and A. Ciechanover. 1997. On the involvement of calpains in the degradation of the tumor suppressor protein p53. FEBS Lett. 406, 17-22 https://doi.org/10.1016/S0014-5793(97)00225-1
- Hartmann-Petersen, R., M. Seeger and C. Gordon. 2003. Transferring substrates to the 26S proteasome. Trends Biochem. Sci. 28, 26-31 https://doi.org/10.1016/S0968-0004(02)00002-6
- Hirai, S., H. Kawasaki, M. Yaniv and K. Suzuki. 1991. Degradation of transcription factors, c-Jun and c-Fos, by calpain. FEBS Lett. 287, 57-61 https://doi.org/10.1016/0014-5793(91)80015-U
- Hunter, T. and J. Pines. 1994. Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age. Cell 79, 573-582 https://doi.org/10.1016/0092-8674(94)90543-6
- Jakobisiak, M., S. Bruno, J. S. Skierski, Z. Darzynkiewicz. 1991. Cell cycle-specific effects of lovastatin. Proc. Natl. Acad. Sci. USA 88, 3628-3632
- Josefsberg, L. B., O. Kaufman, D. Galiani, M. Kovo and N. Dekel. 2001. Inactivation of M-phase promoting factor at exit from first embryonic mitosis in the rat is independent of cyclin B1 degradation. Biol. Reprod. 64, 871-878 https://doi.org/10.1095/biolreprod64.3.871
- King, R. W., R. J. Deshaies, J. M. Peters and M. W. Kirschner. 1996. How proteolysis drives the cell cycle. Science 274, 1652-1659 https://doi.org/10.1126/science.274.5293.1652
- Kubbutat, M. H. and K. H. Vousden. 1997. Proteolytic cleavage of human p53 by calpain: a potential regulator of protein stability. Mol. Cell. Biol. 17, 460-468 https://doi.org/10.1128/MCB.17.1.460
- Lee, S. J., M. J. Ha, J. Lee, P. Nguyen, Y. H. Choi, F. Pirnia, W. K. Kang, X. F. Wang, S. J. Kim and J. B. Trepel. 1998. Inhibition of the 3-hydroxy-3-methylglutaryl-coenzyme A reductase pathway induces p53-independent transcriptional regulation of p21(WAF1/CIP1) in human prostate carcinoma cells. J. Biol. Chem. 273, 10618-10623 https://doi.org/10.1074/jbc.273.17.10618
- Maki, C. G., J. M. Huibregtse and P. M. Howley. 1996. In vivo ubiquitination and proteasome-mediated degradation of p53. Cancer Res. 56, 2649-2654
- Mellgren, R. L. 1980. Canine cardiac calcium-dependent proteases: Resolution of two forms with different requirements for calcium. FEBS Lett. 109, 129-133 https://doi.org/10.1016/0014-5793(80)81326-3
- Mellgren, R. L. 1987. Calcium-dependent proteases: an enzyme system active at cellular membranes? FASEB J. 1, 110-115 https://doi.org/10.1096/fasebj.1.2.2886390
- Mellgren, R. L., Q. Lu, W. Zhang, M. Lakkis, E. Shaw and M. T. Mericle. 1996. Isolation of a Chinese hamster ovary cell clone possessing decreased mu-calpain content and a reduced proliferative growth rate. J. Biol. Chem. 271, 15568-15574 https://doi.org/10.1074/jbc.271.26.15568
- Murachi, T. 1989. Intracellular regulatory system involving calpain and calpastatin. Biochem. Int. 18, 263-294
- Musat, M., V. V. Vax, N. Borboli, M. Gueorguiev, S. Bonner, M. Korbonits and A.B. Grossman. 2004. Cell cycle dysregulation in pituitary oncogenesis. Front. Horm. Res. 32, 34-62 https://doi.org/10.1159/000079037
- Ortega, S., M. Malumbres and M. Barbacid. 2002. Cyclin D-dependent kinases, INK4 inhibitors and cancer. Biochim. Biophys. Acta. 602, 73-87
- Patel, Y. M. and M. D. Lane. 1996. Role of calpain in adipocyte differentiation. Proc. Natl. Acad. Sci. USA 96, 1279-1284
- Roos-Mattjus, P. and L. Sistonen. 2004. The ubiquitin- proteasome pathway. Ann. Med. 36, 285-295 https://doi.org/10.1080/07853890310016324
- Saido, T. C., H. Sorimachi and K. Suzuki. 1994. Calpain: new perspectives in molecular diversity and physiological- pathological involvement. FASEB J. 8, 814-822 https://doi.org/10.1096/fasebj.8.11.8070630
- Sato, K. and S. Kawashima. 2001. Calpain function in the modulation of signal transduction molecules. Biol. Chem. 382, 743-751 https://doi.org/10.1515/BC.2001.090
- Solomon, V. and A. L. Goldberg. 1996. Importance of the ATP-ubiquitin-proteasome pathway in the degradation of soluble and myofibrillar proteins in rabbit muscle extracts. J. Biol. Chem. 271, 26690-26697 https://doi.org/10.1074/jbc.271.43.26690
- Sorimachi, H., T. C. Saido and K. Suzuki. 1994. New era of calpain research. Discovery of tissue-specific calpains. FEBS Lett. 343, 1-5 https://doi.org/10.1016/0014-5793(94)80595-4
- Squier, M. K. and J. J. Cohen. 1997. Calpain, an upstream regulator of thymocyte apoptosis. J. Immunol. 158, 3690-3697
- Squier, M. K., A. J. Sehnert, K. S. Sellins, A. M. alkinson, E. Takano and J. J. Cohen. 1999. Calpain and calpastatin regulate neutrophil apoptosis. J. Cell. Physiol. 178, 311-319 https://doi.org/10.1002/(SICI)1097-4652(199903)178:3<311::AID-JCP5>3.0.CO;2-T
- Suzuki, K. and H. Sorimachi. 1998. A novel aspect of calpain activation. FEBS Lett. 433, 1-4 https://doi.org/10.1016/S0014-5793(98)00856-4
- Suzuki, K., S. Hata, Y. Kawabata and H. Sorimachi. 2004. Structure, activation, and biology of calpain. Diabetes 53, S12-18 https://doi.org/10.2337/diabetes.53.2007.S12
- Walowitz, J. L., M. E. Bradley, S. Chen and T. Lee. 1998. Proteolytic regulation of the zinc finger transcription factor YY1, a repressor of muscle-restricted gene expression. J. Biol. Chem. 273, 6656-6661 https://doi.org/10.1074/jbc.273.12.6656